Lung Cancer is a wide-spread, growing problem in Australia. In 2017, over 12,000 new cases of lung cancer are estimated to be diagnosed.
While most lung diseases are curable when detected early, unfortunately, the disease often presents with little or no symptoms until it has progressed into the incurable and advanced disease stage. This is because traditionally detection of lung cancer occurs when a patient presents to their General Practitioner (GP) with an ongoing cough or shortness of breath.
However, a major clinical trial performed in the United States of America, named the National Lung Screening Trial (NLST) demonstrated a 20% reduction in lung cancer mortality rates when screening was performed with low dose CT, in comparison with a traditional chest X-ray1 There is strong evidence of the advantages of lung screening, using low dose CT, for those individuals at high risk of developing lung disease (particularly amongst cigarette smokers).
If you are concerned about your risk of developing lung cancer, Lungscreen encourages you to consult with your GP or a Specialist on appropriate lung screening options and management available at Lungscreen.